Please assess the completion status of the following clinical trial:

Trial Title: Early Cardioprotective Effect of Sevoflurane

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* the degree I or II of Cardiac Anesthesia Risk Evaluation score~* angiographically verified coronary artery disease~* left ventricular ejection fraction higher than 40%~Exclusion Criteria:~* atrioventricular conduction disturbances~* previously ventricular arrhythmias requiring antiarrhythmic treatment~* atrial fibrillation with rapid ventricular response~* myocardial infarction or stroke within 6 months~* diabetes mellitus~* end-stage of obstructive or restrictive pulmonary disease

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).